Episode Details

Back to Episodes

Costamare (CMRE) Q2 2026: Trading Below Its Own Fleet With a $6 Billion Backlog — Deep Value or Cyclical Trap?

Published 3 months ago
Description
Costamare Inc. (CMRE) Q2 2026 — Costamare Inc. (NYSE: CMRE), one of the largest independent owners of containerships in the world, reported Q2 2026 (quarter ended June 30, 2026) before the open on July 27. This is now a focused container-plus-leasing company: Costamare spun off its entire dry-bulk business (Costamare Bulkers, NYSE: CMDB) in May 2025, so all figures here are continuing operations. Adjusted net income from continuing operations to common was $75.1M ($0.62/sh), a beat versus the ~$0.57 consensus but down ~19% from $0.77 a year ago as the containership charter cycle normalizes off its post-pandemic peak. GAAP net income to common was $77.4M ($0.64/sh). Voyage revenue was ~$200.8M (−4.8% YoY, a touch above the ~$193-197M estimate), and liquidity was strong at $423.0M. The bull case is visibility and de-risking: ~$6.1B of already-contracted charter revenue with a 5.9-year TEU-weighted duration, with 97% of the containership fleet fixed for 2026 and 94% for 2027; a $920M block of new financing plus $331M more lined up, which pushed all debt maturities out to 2030 at lower cost; net-debt/EBITDA ~1.5x; a controlling interest in Neptune Maritime Leasing (50 shipping assets funded/committed, $700M+ invested/committed); and a 16-ship newbuild containership program with the required equity already paid in full. The stock trades at ~0.87x book (stated NAV ~$18/share), ~6x earnings, and pays a covered $0.50/yr dividend (~3.2% yield) at ~$15.60. Our owner-earnings + NAV valuation lands fair value near $17 — a normalizing-cycle DCF in the mid-teens blended with a backlog/re-charter case near book. Our call: BUY, 3/5 — a de-risked, deep-value shipper trading below the value of its own fleet with years of contracted cash flow, best owned by patient, income-oriented investors who accept cyclicality. Wall Street rates CMRE a Hold with an average target near $13 — about 17% BELOW the current price — so the market has bid the stock above the sell-side. We DIFFER (more bullish): we weight the asset discount and the de-risking more heavily than the falling earnings trend, while respecting that the Street's caution on shipping is well-earned. Not financial advice. Costamare (NYSE: CMRE) is one of the largest independent owners of containerships in the world — it buys the big vessels and charters them, on multi-year contracts, to the major liner operators, with a controlling interest in the growing Neptune Maritime Leasing platform bolted on. Note the company changed shape: it spun off its entire dry-bulk business (Costamare Bulkers, CMDB) in May 2025, so Q2 2026 is a clean look at the continuing container-plus-leasing company. The quarter was a beat against a fading trend: adjusted EPS of $0.62 topped the ~$0.57 estimate but fell ~19% from $0.77 a year ago as containership charter rates normalize off the post-pandemic boom; GAAP net income to common was $77.4M ($0.64/sh); voyage revenue ~$200.8M (−4.8% YoY); liquidity $423M. What makes it interesting is the mismatch between price and coverage. The stock at ~$15.60 trades below the ~$18 book value of its own fleet (~0.87x), at ~6x earnings, and pays a covered ~3.2% dividend — yet the handful of analysts who cover it rate it Hold with an average target near $13, about 17% BELOW the price. The bull case is de-risking and visibility: ~$6.1B of contracted charter revenue with a 5.9-year duration (97%/94% of the fleet fixed for 2026/2027), a refinancing wave that pushed all debt maturities out to 2030, net-debt/EBITDA ~1.5x, and a 16-ship newbuild program with equity already paid in. The bear case is the cycle: earnings down 19%, new vessel supply arriving into a softening market, and a leveraged, asset-heavy balance sheet. Our NAV-plus-owner-earnings valuation lands fair value near $17 — high-single-digit upside plus the yield. Our call: BUY, 3/5 — a deep-value, de-risked shipper trading below its own assets, for patient income investors who understand cyclicals; not a growth story and not
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us